VITAMIN D AND MULTIPLE SCLEROSIS

Kamalova N.L.,Nurmatov T.A.

Authors

Kamalova N.L.,Nurmatov T.A. Department of Neurology. ASMI.

Keywords:

nutritional behavior, hyperbaric oxygen therapy, genetics, immune response genes, diet, disability, cognitive impairment, vitamine D.

Abstract

Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS) - the brain and spinal cord, characterized by the development of demyelination foci scattered in time and space and diffuse changes in brain tissue, which is clinically manifested by multifocal neurological symptoms. MS is one of the severe forms of organic damage to the nervous system, which mainly affects young and working-age people, which leads to a decrease in their quality of life and the development of disability.

References

Boyko A, Smirnova N, Petrov S, Gusev E. Epidemiology of MS in Russia, a historical review. Mult Scler Demyelinating Disord. 2016; 1: 1–6. DOI: 10.1186/s40893-016-0016-9

Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015; 15: 545–58. DOI: 10.1038/nri3871

Beckmann Y, Türe S, Duman SU. Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients. EPMA Journal. 2020;11: 65–72. DOI: 10.1007/s13167-019-00191-0

Tarlinton RE, Khaibullin T, Granatov E, et al. The interaction between viral and environmental risk factors in the pathogenesis of multiple sclerosis. Int J Mol Sci. 2019; 20 (2): 303. DOI: 10.3390/ijms20020303

Dobson R, Giovannoni G. Multiple sclerosis – a review. Eur J Neurol. 2019; 26 (1): 27–40. DOI: 10.1111/ene.13819

Thompson AJ, Baranzini SE, Geurts J, Hemmer B. Multiple sclerosis. Lancet. 2018; 391 (10130): 1622–36. DOI: 10.1016/S0140-6736(18)30481-1

Sospedra M, Martin R. Immunology of Multiple Sclerosis. Semin Neurol. 2016; 36 (02): 115–27. DOI: 10.1055/s-0036-1579739

Hupperts R, Smolders J, Vieth R, et al. Randomized trial of daily high-dose Vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a. Neurology. 2019; 93 (20): E1906–16. DOI: 10.1212/WNL.0000000000008445